Asthma Control Study 2011

Asthma Control Level Clinical Trial

Official title:

Asthma Control Study 2011

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01298739
• Other study ID #: NIS-RHU-XXX-2011/1
• Status: Completed
• Phase: N/A
• First received: February 16, 2011
• Last updated: October 24, 2011
• Start date: February 2011
• Est. completion date: October 2011

Study information

• Verified date: October 2011
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Hungary: National Institute of Pharmacy
• Study type: Observational

Clinical Trial Summary

Asthma control study 2011

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1524
• Est. completion date: October 2011
• Est. primary completion date: October 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Asthmatic patients above 18 y

Exclusion Criteria:

• COPD

• pulmonary cancer

• pulmonary tuberculosis

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Asthma
• Asthma Control Level

Locations

Country	Name	City	State
Hungary	Research Site	Adásztevel
Hungary	Research Site	Ajka
Hungary	Research Site	Albertirsa
Hungary	Research Site	Baja
Hungary	Research Site	Balatonendréd
Hungary	Research Site	Békés
Hungary	Research Site	Békéscsaba
Hungary	Research Site	Budajeno
Hungary	Research Site	Budakeszi
Hungary	Research Site	Budapest
Hungary	Research Site	Celldömölk
Hungary	Research Site	Dabas
Hungary	Research Site	Debrecen
Hungary	Research Site	Dombóvár
Hungary	Research Site	Dunaújváros
Hungary	Research Site	Edelény
Hungary	Research Site	Eger
Hungary	Research Site	Encs
Hungary	Research Site	Esztergom
Hungary	Research Site	Gyöngyös
Hungary	Research Site	Gyor
Hungary	Research Site	Gyula
Hungary	Research Site	Hatvan
Hungary	Research Site	Hódmezovásárhely
Hungary	Research Site	Kaposvár
Hungary	Research Site	Kecskemét
Hungary	Research Site	Kisbér
Hungary	Research Site	Kiskunfélegyháza
Hungary	Research Site	Kiskunhalas
Hungary	Research Site	Komárom
Hungary	Research Site	Körmend
Hungary	Research Site	Lenti
Hungary	Research Site	Mátraháza
Hungary	Research Site	Miskolc
Hungary	Research Site	Monor
Hungary	Research Site	Mór
Hungary	Research Site	Mosdós
Hungary	Research Site	Nagykanizsa
Hungary	Research Site	Nyíregyháza
Hungary	Research Site	Paks
Hungary	Research Site	Pécs
Hungary	Research Site	Sopron
Hungary	Research Site	Szarvas
Hungary	Research Site	Szeged
Hungary	Research Site	Székesfehérvár
Hungary	Research Site	Szombathely
Hungary	Research Site	Tata
Hungary	Research Site	Tatabánya
Hungary	Research Site	Tiszaújváros
Hungary	Research Site	Törökbálint
Hungary	Research Site	Törökszentmiklós
Hungary	Research Site	Veszprém
Hungary	Research Site	Zalaegerszeg

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Country where clinical trial is conducted

Hungary, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Asthma control level		2 times	No
Secondary	Routine Therapeutical habits in control maintenance		2 time	No